|
Q |
GWAS1058385_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058385 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:18,047,613...18,047,614
|
|
Q |
GWAS1058386_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1058386 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:27,576,974...27,576,975
|
|
Q |
GWAS1058387_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058387 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:191,266,812...191,266,813
|
|
Q |
GWAS1058388_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058388 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 2:217,021,378...217,021,379
|
|
Q |
GWAS1058389_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058389 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:28,773,701...28,773,702
|
|
Q |
GWAS1058390_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058390 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:188,009,513...188,009,514
|
|
Q |
GWAS1058391_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1058391 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:34,517,105...34,517,106
|
|
Q |
GWAS609241_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS609241 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr13:60,294,764...60,294,765
|
|
Q |
GWAS609245_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS609245 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:231,038,685...231,038,686
|
|
Q |
GWAS609246_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS609246 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:63,071,766...63,071,767
|
|
Q |
GWAS609256_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609256 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:59,276,950...59,276,951
|
|
Q |
GWAS609265_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609265 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:59,957,291...59,957,292
|
|
Q |
GWAS609266_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609266 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:30,870,751...30,870,752
|
|
Q |
GWAS609274_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609274 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:30,843,681...30,843,682
|
|
Q |
GWAS609275_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609275 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:27,794,997...27,794,998
|
|
Q |
GWAS609277_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609277 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 8:99,885,580...99,885,581
|
|
Q |
GWAS609418_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609418 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:55,046,103...55,046,104
|
|
Q |
GWAS609419_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609419 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:56,534,912...56,534,913
|
|
Q |
GWAS609420_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609420 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 4:32,053,616...32,053,617
|
|
Q |
GWAS609422_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609422 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr14:65,566,216...65,566,217
|
|
Q |
GWAS609423_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609423 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,341,212...98,341,213
|
|
Q |
GWAS609424_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609424 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:84,708,147...84,708,148
|
|
Q |
GWAS609425_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609425 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:106,621,114...106,621,115
|
|
Q |
GWAS609426_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609426 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr17:33,615,673...33,615,674
|
|
Q |
GWAS609427_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS609427 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,178,332...98,178,333
|
|
Q |
GWAS610380_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610380 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 2:219,706,616...219,706,617
|
|
Q |
GWAS610381_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610381 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:67,503,800...67,503,801
|
|
Q |
GWAS610449_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610449 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:121,406,910...121,406,911
|
|
Q |
GWAS610452_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610452 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:36,510,951...36,510,952
|
|
Q |
GWAS610453_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610453 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr22:17,197,777...17,197,778
|
|
Q |
GWAS610454_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610454 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr10:13,178,143...13,178,144
|
|
Q |
GWAS610455_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610455 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 6:143,713,654...143,713,655
|
|
Q |
GWAS610456_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS610456 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:58,956,910...58,956,911
|
|
Q |
GWAS610457_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610457 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q |
GWAS610458_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610458 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:84,688,251...84,688,252
|
|
Q |
GWAS610459_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610459 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:1,449,555...1,449,556
|
|
Q |
GWAS610460_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610460 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:17,557,558...17,557,559
|
|
Q |
GWAS610461_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610461 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q |
GWAS610462_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610462 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:99,677,789...99,677,790
|
|
Q |
GWAS610464_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS610464 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr12:116,414,208...116,414,209
|
|
Q |
GWAS614144_H |
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS614144 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:9,515,044...9,515,045
|
|
Q |
GWAS676268_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676268 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:177,037,120...177,037,121
|
|
Q |
GWAS676269_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676269 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:29,787,674...29,787,675
|
|
Q |
GWAS676270_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676270 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr14:27,094,703...27,094,704
|
|
Q |
GWAS676271_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676271 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 8:58,320,850...58,320,851
|
|
Q |
GWAS676272_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676272 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:92,602,998...92,602,999
|
|
Q |
GWAS676414_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676414 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr17:33,499,023...33,499,024
|
|
Q |
GWAS676415_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676415 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:102,433,268...102,433,269
|
|
Q |
GWAS676416_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676416 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr21:40,495,416...40,495,417
|
|
Q |
GWAS676417_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676417 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q |
GWAS676418_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676418 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:64,066,290...64,066,291
|
|
Q |
GWAS676419_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676419 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:79,038,687...79,038,688
|
|
Q |
GWAS676420_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676420 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr12:120,975,368...120,975,369
|
|
Q |
GWAS676421_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676421 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:9,943,012...9,943,013
|
|
Q |
GWAS676422_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676422 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:78,062,192...78,062,193
|
|
Q |
GWAS676423_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676423 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr10:105,346,612...105,346,613
|
|
Q |
GWAS676424_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS676424 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 9:134,468,823...134,468,824
|
|
Q |
GWAS745744_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745744 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:29,765,192...29,765,193
|
|
Q |
GWAS745746_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745746 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:92,577,246...92,577,247
|
|
Q |
GWAS745750_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745750 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr12:101,572,474...101,572,475
|
|
Q |
GWAS745751_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745751 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q |
GWAS745752_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745752 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:85,499,025...85,499,026
|
|
Q |
GWAS745755_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745755 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:38,616,010...38,616,011
|
|
Q |
GWAS745760_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745760 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:87,616,630...87,616,631
|
|
Q |
GWAS745762_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745762 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:7,274,680...7,274,681
|
|
Q |
GWAS745763_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745763 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr13:24,185,159...24,185,160
|
|
Q |
GWAS745765_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745765 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:80,012,872...80,012,873
|
|
Q |
GWAS745989_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745989 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:135,299,948...135,299,949
|
|
Q |
GWAS745990_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745990 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:149,299,495...149,299,496
|
|
Q |
GWAS745992_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS745992 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr14:93,891,857...93,891,858
|
|
Q |
GWAS779465_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779465 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:29,807,885...29,807,886
|
|
Q |
GWAS779469_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779469 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:29,943,062...29,943,063
|
|
Q |
GWAS779470_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779470 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,262,577...32,262,578
|
|
Q |
GWAS779472_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779472 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,713,500...32,713,501
|
|
Q |
GWAS779677_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779677 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr14:106,703,184...106,703,185
|
|
Q |
GWAS779681_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779681 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q |
GWAS779687_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779687 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr16:28,986,676...28,986,677
|
|
Q |
GWAS779688_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779688 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr13:44,367,675...44,367,676
|
|
Q |
GWAS779904_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779904 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,214...32,663,215
|
|
Q |
GWAS779909_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS779909 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,478,492...32,478,493
|
|
Q |
GWAS780160_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS780160 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,679...32,663,680
|
|
Q |
GWAS780162_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS780162 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:30,631,399...30,631,400
|
|
Q |
GWAS780164_H |
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS780164 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:29,850,253...29,850,254
|
|
Q |
GWAS943816_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS943816 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38575714 |
|
NCBI chr 6:29,937,416...29,937,417
|
|
Q |
GWAS944103_H |
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS944103 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:38575714 |
|
NCBI chr 6:31,396,328...31,396,329
|
|
|
Q |
GWAS556228_H |
Epstein-Barr virus seropositivity QTL GWAS556228 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,138,632...31,138,633
|
|
Q |
GWAS556478_H |
Epstein-Barr virus seropositivity QTL GWAS556478 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,659,970...32,659,971
|
|
Q |
GWAS557159_H |
Epstein-Barr virus seropositivity QTL GWAS557159 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,138,632...31,138,633
|
|
Q |
GWAS576123_H |
anti-Epstein Barr virus antibody measurement QTL GWAS576123 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:34804013 |
|
NCBI chr 7:40,250,217...40,250,218
|
|
Q |
GWAS589654_H |
Epstein-Barr virus seropositivity QTL GWAS589654 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36737699 |
|
NCBI chr 6:105,322,133...105,322,134
|
|
Q |
GWAS589655_H |
Epstein-Barr virus seropositivity QTL GWAS589655 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:36737699 |
|
NCBI chr13:114,072,886...114,072,887
|
|
Q |
GWAS619807_H |
anti-Epstein Barr virus antibody measurement QTL GWAS619807 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:29868224 |
|
NCBI chr 6:32,636,877...32,636,878
|
|
Q |
GWAS624905_H |
anti-Epstein Barr virus antibody measurement QTL GWAS624905 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:410,848...410,849
|
|
Q |
GWAS624962_H |
anti-Epstein Barr virus antibody measurement QTL GWAS624962 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:32,479,867...32,479,868
|
|
Q |
GWAS624964_H |
anti-Epstein Barr virus antibody measurement QTL GWAS624964 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 3:151,397,064...151,397,065
|
|
Q |
GWAS785728_H |
anti-Epstein Barr virus antibody measurement QTL GWAS785728 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:32,644,620...32,644,621
|
|
Q |
GWAS801977_H |
Epstein-Barr virus seropositivity QTL GWAS801977 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,422,801...32,422,802
|
|
Q |
GWAS801983_H |
Epstein-Barr virus seropositivity QTL GWAS801983 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,152,121...32,152,122
|
|
Q |
GWAS801985_H |
Epstein-Barr virus seropositivity QTL GWAS801985 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,282,210...32,282,211
|
|
Q |
GWAS801986_H |
Epstein-Barr virus seropositivity QTL GWAS801986 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,968,891...31,968,892
|
|
Q |
GWAS801990_H |
Epstein-Barr virus seropositivity QTL GWAS801990 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,641,044...32,641,045
|
|
Q |
GWAS801992_H |
Epstein-Barr virus seropositivity QTL GWAS801992 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,599,645...31,599,646
|
|
Q |
GWAS801996_H |
Epstein-Barr virus seropositivity QTL GWAS801996 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,380,687...31,380,688
|
|
Q |
GWAS801999_H |
Epstein-Barr virus seropositivity QTL GWAS801999 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 1:236,874,861...236,874,862
|
|
Q |
GWAS802218_H |
Epstein-Barr virus seropositivity QTL GWAS802218 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,476,301...32,476,302
|
|
Q |
GWAS802221_H |
Epstein-Barr virus seropositivity QTL GWAS802221 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,240,547...32,240,548
|
|
Q |
GWAS802222_H |
Epstein-Barr virus seropositivity QTL GWAS802222 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,581,579...32,581,580
|
|
Q |
GWAS802225_H |
Epstein-Barr virus seropositivity QTL GWAS802225 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,690,550...32,690,551
|
|
Q |
GWAS802230_H |
Epstein-Barr virus seropositivity QTL GWAS802230 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,608,849...32,608,850
|
|
Q |
GWAS802231_H |
Epstein-Barr virus seropositivity QTL GWAS802231 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,467,561...32,467,562
|
|
Q |
GWAS802233_H |
Epstein-Barr virus seropositivity QTL GWAS802233 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,714,652...32,714,653
|
|
Q |
GWAS802942_H |
Epstein-Barr virus seropositivity QTL GWAS802942 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,583,676...32,583,677
|
|
Q |
GWAS804550_H |
Epstein-Barr virus seropositivity QTL GWAS804550 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,652,509...32,652,510
|
|
Q |
GWAS804552_H |
Epstein-Barr virus seropositivity QTL GWAS804552 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,709,636...32,709,637
|
|
Q |
GWAS804555_H |
Epstein-Barr virus seropositivity QTL GWAS804555 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,243,288...32,243,289
|
|
Q |
GWAS804557_H |
Epstein-Barr virus seropositivity QTL GWAS804557 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr10:83,404,030...83,404,031
|
|
Q |
GWAS804558_H |
Epstein-Barr virus seropositivity QTL GWAS804558 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr16:75,684,574...75,684,575
|
|
Q |
GWAS804559_H |
Epstein-Barr virus seropositivity QTL GWAS804559 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,635,544...32,635,545
|
|
Q |
GWAS804560_H |
Epstein-Barr virus seropositivity QTL GWAS804560 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 5:132,419,312...132,419,313
|
|
Q |
GWAS804810_H |
Epstein-Barr virus seropositivity QTL GWAS804810 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,454,348...32,454,349
|
|
Q |
GWAS804815_H |
Epstein-Barr virus seropositivity QTL GWAS804815 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,692,061...32,692,062
|
|
Q |
GWAS804816_H |
Epstein-Barr virus seropositivity QTL GWAS804816 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,245,373...32,245,374
|
|
Q |
GWAS804826_H |
Epstein-Barr virus seropositivity QTL GWAS804826 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
|
|
Q |
GWAS804827_H |
Epstein-Barr virus seropositivity QTL GWAS804827 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,141,388...32,141,389
|
|
Q |
GWAS804828_H |
Epstein-Barr virus seropositivity QTL GWAS804828 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,912,834...31,912,835
|
|
Q |
GWAS804829_H |
Epstein-Barr virus seropositivity QTL GWAS804829 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,013,369...32,013,370
|
|
Q |
GWAS804831_H |
Epstein-Barr virus seropositivity QTL GWAS804831 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,614,510...31,614,511
|
|
Q |
GWAS805286_H |
Epstein-Barr virus seropositivity QTL GWAS805286 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,819,140...32,819,141
|
|
Q |
GWAS805289_H |
Epstein-Barr virus seropositivity QTL GWAS805289 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,755,612...31,755,613
|
|
Q |
GWAS805290_H |
Epstein-Barr virus seropositivity QTL GWAS805290 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,310,858...32,310,859
|
|
Q |
GWAS805291_H |
Epstein-Barr virus seropositivity QTL GWAS805291 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,355,111...31,355,112
|
|
Q |
GWAS805292_H |
Epstein-Barr virus seropositivity QTL GWAS805292 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,074,545...32,074,546
|
|
Q |
GWAS805295_H |
Epstein-Barr virus seropositivity QTL GWAS805295 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,727,598...32,727,599
|
|
Q |
GWAS805876_H |
Epstein-Barr virus seropositivity QTL GWAS805876 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,614,800...32,614,801
|
|
Q |
GWAS806375_H |
Epstein-Barr virus seropositivity QTL GWAS806375 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,632,280...32,632,281
|
|
Q |
GWAS806378_H |
Epstein-Barr virus seropositivity QTL GWAS806378 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,471,300...32,471,301
|
|
Q |
GWAS806381_H |
Epstein-Barr virus seropositivity QTL GWAS806381 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,593,346...32,593,347
|
|
Q |
GWAS806562_H |
Epstein-Barr virus seropositivity QTL GWAS806562 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,069...32,710,070
|
|
Q |
GWAS806571_H |
Epstein-Barr virus seropositivity QTL GWAS806571 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,608,987...32,608,988
|
|
Q |
GWAS806572_H |
Epstein-Barr virus seropositivity QTL GWAS806572 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,310,858...32,310,859
|
|
Q |
GWAS806579_H |
Epstein-Barr virus seropositivity QTL GWAS806579 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:30,987,836...30,987,837
|
|
Q |
GWAS806580_H |
Epstein-Barr virus seropositivity QTL GWAS806580 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,712,345...32,712,346
|
|
Q |
GWAS806581_H |
Epstein-Barr virus seropositivity QTL GWAS806581 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,481,746...32,481,747
|
|
Q |
GWAS806791_H |
Epstein-Barr virus seropositivity QTL GWAS806791 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,659,996...32,659,997
|
|
Q |
GWAS806792_H |
Epstein-Barr virus seropositivity QTL GWAS806792 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,606,531...32,606,532
|
|
Q |
GWAS806814_H |
Epstein-Barr virus seropositivity QTL GWAS806814 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q |
GWAS806815_H |
Epstein-Barr virus seropositivity QTL GWAS806815 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,361,595...31,361,596
|
|
Q |
GWAS806816_H |
Epstein-Barr virus seropositivity QTL GWAS806816 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q |
GWAS806821_H |
Epstein-Barr virus seropositivity QTL GWAS806821 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,465,982...32,465,983
|
|
Q |
GWAS806822_H |
Epstein-Barr virus seropositivity QTL GWAS806822 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 7:153,890,200...153,890,201
|
|
Q |
GWAS806827_H |
Epstein-Barr virus seropositivity QTL GWAS806827 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q |
GWAS806832_H |
Epstein-Barr virus seropositivity QTL GWAS806832 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,465,982...32,465,983
|
|
Q |
GWAS806833_H |
Epstein-Barr virus seropositivity QTL GWAS806833 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,463,781...32,463,782
|
|
Q |
GWAS807074_H |
Epstein-Barr virus seropositivity QTL GWAS807074 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,069...32,710,070
|
|
Q |
GWAS807774_H |
Epstein-Barr virus seropositivity QTL GWAS807774 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,400,018...32,400,019
|
|
Q |
GWAS807775_H |
Epstein-Barr virus seropositivity QTL GWAS807775 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q |
GWAS807776_H |
Epstein-Barr virus seropositivity QTL GWAS807776 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,617,175...32,617,176
|
|
Q |
GWAS807777_H |
Epstein-Barr virus seropositivity QTL GWAS807777 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q |
GWAS807778_H |
Epstein-Barr virus seropositivity QTL GWAS807778 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q |
GWAS807779_H |
Epstein-Barr virus seropositivity QTL GWAS807779 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q |
GWAS807780_H |
Epstein-Barr virus seropositivity QTL GWAS807780 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q |
GWAS807785_H |
Epstein-Barr virus seropositivity QTL GWAS807785 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,373,576...32,373,577
|
|
Q |
GWAS807787_H |
Epstein-Barr virus seropositivity QTL GWAS807787 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,627,370...32,627,371
|
|
Q |
GWAS807823_H |
streptococcus seropositivity QTL GWAS807823 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,231,367...32,231,368
|
|
Q |
GWAS808019_H |
Epstein-Barr virus seropositivity QTL GWAS808019 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,599,774...32,599,775
|
|
Q |
GWAS808030_H |
Epstein-Barr virus seropositivity QTL GWAS808030 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,617,175...32,617,176
|
|
Q |
GWAS808269_H |
Epstein-Barr virus seropositivity QTL GWAS808269 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,482,901...32,482,902
|
|
Q |
GWAS808270_H |
Epstein-Barr virus seropositivity QTL GWAS808270 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q |
GWAS808271_H |
Epstein-Barr virus seropositivity QTL GWAS808271 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,607,958...32,607,959
|
|
Q |
GWAS808273_H |
Epstein-Barr virus seropositivity QTL GWAS808273 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:33,115,411...33,115,412
|
|
Q |
GWAS808281_H |
Epstein-Barr virus seropositivity QTL GWAS808281 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:33,000,710...33,000,711
|
|
Q |
GWAS808471_H |
Epstein-Barr virus seropositivity QTL GWAS808471 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q |
GWAS808472_H |
Epstein-Barr virus seropositivity QTL GWAS808472 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q |
GWAS808473_H |
Epstein-Barr virus seropositivity QTL GWAS808473 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,378,714...32,378,715
|
|
Q |
GWAS808474_H |
Epstein-Barr virus seropositivity QTL GWAS808474 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 1:9,454,514...9,454,515
|
|
Q |
GWAS808477_H |
Epstein-Barr virus seropositivity QTL GWAS808477 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,614,800...32,614,801
|
|
Q |
GWAS808478_H |
Epstein-Barr virus seropositivity QTL GWAS808478 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,476,301...32,476,302
|
|
Q |
GWAS808479_H |
Epstein-Barr virus seropositivity QTL GWAS808479 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,373,576...32,373,577
|
|
Q |
GWAS808722_H |
Epstein-Barr virus seropositivity QTL GWAS808722 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q |
GWAS808723_H |
Epstein-Barr virus seropositivity QTL GWAS808723 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,644,620...32,644,621
|
|
Q |
GWAS808725_H |
Epstein-Barr virus seropositivity QTL GWAS808725 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q |
GWAS808727_H |
Epstein-Barr virus seropositivity QTL GWAS808727 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,593,316...32,593,317
|
|
Q |
GWAS808731_H |
Epstein-Barr virus seropositivity QTL GWAS808731 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr18:2,828,701...2,828,702
|
|
Q |
GWAS808733_H |
Epstein-Barr virus seropositivity QTL GWAS808733 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,190,542...32,190,543
|
|
Q |
GWAS808738_H |
Epstein-Barr virus seropositivity QTL GWAS808738 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 2:85,741,456...85,741,457
|
|
Q |
GWAS808739_H |
Epstein-Barr virus seropositivity QTL GWAS808739 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,395,438...32,395,439
|
|
Q |
GWAS808740_H |
Epstein-Barr virus seropositivity QTL GWAS808740 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,633,043...31,633,044
|
|
Q |
GWAS808741_H |
Epstein-Barr virus seropositivity QTL GWAS808741 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 2:85,741,456...85,741,457
|
|
Q |
GWAS808953_H |
Epstein-Barr virus seropositivity QTL GWAS808953 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,866...32,461,867
|
|
Q |
GWAS808954_H |
Epstein-Barr virus seropositivity QTL GWAS808954 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,604,271...32,604,272
|
|
Q |
GWAS808955_H |
Epstein-Barr virus seropositivity QTL GWAS808955 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,135...32,710,136
|
|
Q |
GWAS808956_H |
Epstein-Barr virus seropositivity QTL GWAS808956 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,550...32,461,551
|
|
Q |
GWAS808957_H |
Epstein-Barr virus seropositivity QTL GWAS808957 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,604,271...32,604,272
|
|
Q |
GWAS808958_H |
Epstein-Barr virus seropositivity QTL GWAS808958 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,135...32,710,136
|
|
Q |
GWAS808959_H |
Epstein-Barr virus seropositivity QTL GWAS808959 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,636,048...32,636,049
|
|
Q |
GWAS808960_H |
Epstein-Barr virus seropositivity QTL GWAS808960 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,550...32,461,551
|
|
Q |
GWAS808961_H |
Epstein-Barr virus seropositivity QTL GWAS808961 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,866...32,461,867
|
|
Q |
GWAS808962_H |
Epstein-Barr virus seropositivity QTL GWAS808962 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,624,560...32,624,561
|
|
Q |
GWAS808965_H |
Epstein-Barr virus seropositivity QTL GWAS808965 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,947,158...31,947,159
|
|
Q |
GWAS808966_H |
Epstein-Barr virus seropositivity QTL GWAS808966 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,251,543...32,251,544
|
|
Q |
GWAS808969_H |
Epstein-Barr virus seropositivity QTL GWAS808969 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,639,834...32,639,835
|
|
Q |
GWAS808970_H |
Epstein-Barr virus seropositivity QTL GWAS808970 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,460,285...32,460,286
|
|
Q |
GWAS808971_H |
Epstein-Barr virus seropositivity QTL GWAS808971 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,644,000...31,644,001
|
|
Q |
GWAS808972_H |
Epstein-Barr virus seropositivity QTL GWAS808972 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q |
GWAS808973_H |
Epstein-Barr virus seropositivity QTL GWAS808973 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,639,834...32,639,835
|
|
Q |
GWAS808974_H |
Epstein-Barr virus seropositivity QTL GWAS808974 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,179,984...32,179,985
|
|
Q |
GWAS808975_H |
Epstein-Barr virus seropositivity QTL GWAS808975 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,400,018...32,400,019
|
|
Q |
GWAS858955_H |
anti-Epstein Barr virus antibody measurement QTL GWAS858955 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:26,370,479...26,370,480
|
|
Q |
GWAS923976_H |
anti-Epstein Barr virus antibody measurement QTL GWAS923976 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 7:11,181,685...11,181,686
|
|
Q |
GWAS923978_H |
anti-Epstein Barr virus antibody measurement QTL GWAS923978 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:32,622,201...32,622,202
|
|
Q |
GWAS923979_H |
anti-Epstein Barr virus antibody measurement QTL GWAS923979 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:33204752 |
|
NCBI chr 6:27,752,924...27,752,925
|
|
Q |
GWAS988850_H |
Epstein-Barr virus seropositivity QTL GWAS988850 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,353,033...31,353,034
|
|
Q |
GWAS988852_H |
Epstein-Barr virus seropositivity QTL GWAS988852 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,623,832...32,623,833
|
|
Q |
GWAS988854_H |
Epstein-Barr virus seropositivity QTL GWAS988854 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,353,033...31,353,034
|
|
Q |
GWAS997702_H |
Epstein-Barr virus seropositivity QTL GWAS997702 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,660,921...32,660,922
|
|
Q |
GWAS997703_H |
Epstein-Barr virus seropositivity QTL GWAS997703 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,660,921...32,660,922
|
|
|
Q |
GWAS1014014_H |
rheumatoid factor seropositivity measurement, rheumatoid factor measurement QTL GWAS1014014 (human) |
|
IAGP |
Based on the EFO term ID |
GWAS_CATALOG |
PMID:26815016 |
|
NCBI chr 5:3,670,892...3,670,893
|
|